![Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex]()
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexZawistowski, Jon S.; Bevill, Samantha M.; Goulet, Daniel R.; Stuhlmiller, Timothy J.; Beltran, Adriana S.; Olivares-Quintero, Jose F.; Singh, Darshan; Sciaky, Noah; Parker, Joel S.; Rashid, Naim U.; Chen, Xin; Duncan, James S.; Whittle, Martin C.; Angus, Steven P.; Velarde, Sara Hanna; Golitz, Brian T.; He, Xiaping; Santos, Charlene; Darr, David B.; Gallagher, Kristalyn; Graves, Lee M.; Perou, Charles M.; Carey, Lisa A.; Earp, H. Shelton; Johnson, Gary L. · Cancer Discovery · 2017